Search Results 1351-1360 of 16409 for Rodent
Surrogate Endpoints Poor Proxy for Survival in Cancer Drug Approval Process featured image · Discovery's Edge: First Cure With a New Drug featured image · Chemo, ...
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
A recent Mayo Clinic retrospective study shows that cancer practices can integrate telehealth without duplicative care, allowing for a more streamlined ...
Marla Broadfoot, Ph.D. March 26, 2026. Immunotherapy boosts chemotherapy in combating stage 3 colon cancer featured image. Cancer.
Latest stories · Delivering innovative stem cell therapy to slow vision loss featured image · Mayo Clinic Q&A podcast: Addressing disparities to prevent disease ...
ROCHESTER, Minn. — Early detection is key to breast cancer survival. But nearly half of all women in the U.S. have dense breast tissue, which can make ...
Mayo Clinic researchers found a potential way to improve access for patients with end-stage kidney disease to hemodialysis. Latest stories.
There are several breast cancer subtypes. The growth of hormone-dependent breast cancer, the most common subtype, is driven by female hormones. Another common ...
Researchers revealed what appeared to be two separate health conditions stemmed from a single, shared genetic variant. Latest stories.
ROCHESTER, Minn. — A Mayo Clinic study finds that a shortened, less intense course of radiation and chemotherapy after minimally invasive surgery for HPV- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.